Latest developments in antithrombotic therapy in patients with lower extremity arterial disease

Maria Beatrice Forte; Cecilia Becattini; Giancarlo Agnelli

doi:10.1016/j.rvm.2013.11.001

Related publications

Article2024

Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

Azita H. Talasaz, Parham Sadeghipour, Luis Ortega‐Paz, Hessam Kakavand, Maryam Aghakouchakzadeh, Craig J. Beavers, John Fanikos, John W. Eikelboom, Deborah Siegal, Manuel Monréal, David Jiménez, Muthiah Vaduganathan, Lana A. Castellucci, Adam Cuker, Geoffrey D. Barnes, Jean M. Connors, Eric A. Secemsky, Benjamín Van Tassell, Raffaele De Caterina, Jacob E. Kurlander, Ali Aminian, Gregory Piazza, Samuel Z. Goldhaber, Lisa K. Moores, Saskia Middeldorp, Ajay J. Kirtane, Mitchell S.V. Elkind, Dominick J. Angiolillo, Stavros Konstantinides, Professor Gregory Lip, Gregg W. Stone, Mary Cushman, Harlan M. Krumholz, Roxana Mehran, Deepak L. Bhatt, Behnood Bikdeli

Article2023

Latest developments in antithrombotic therapy in patients with lower extremity arterial disease

Discussion(0)

Related publications

Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19

Antithrombotic Therapy for Venous Thromboembolic Disease

Prevalence and Correlates of Lower-Extremity Amputation in Patients With Diabetic Foot Ulcer in Jeddah, Saudi Arabia

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease